Vistin Pharma — Major Shareholding Notification 2023

Aug 26, 2023

Mandatory notification of trade in Vistin Pharma ASA

Mandatory notification of trade in Vistin Pharma ASA

Ferncliff Listed DAI AS has on 25 August 2023 purchased 200,000 shares in Vistin

Pharma ASA at NOK 21 per share.

After the transaction Ferncliff Listed DAI AS has a holding of 1,234,280 shares,

corresponding to 2,78% ownership. Ferncliff Listed DAI AS is closely associated

with board member Øystein Stray Spetalen.